Heron Therapeutics Inc. buy Rodman & Renshaw
Start price
13.06.24
/
50%
€3.38
Target price
13.06.25
€6.48
Performance (%)
-50.35%
Price
22.08.24
€1.68
Summary
This prediction is currently active. The BUY prediction by Rodman___Renshaw for Heron Therapeutics Inc. is performing very badly with a performance of -50.35%. This prediction currently runs until 13.06.25. The prediction end date can be changed by Rodman___Renshaw at any time. Rodman___Renshaw has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Heron Therapeutics Inc. | -3.835% | -3.835% |
iShares Core DAX® | 1.665% | 0.362% |
iShares Nasdaq 100 | -0.475% | -3.195% |
iShares Nikkei 225® | 2.620% | 1.174% |
iShares S&P 500 | -0.091% | -1.597% |
Comments by Rodman___Renshaw for this prediction
In the thread Heron Therapeutics Inc. diskutieren
Heron Therapeutics, Inc. (NASDAQ: HRTX) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $7.00 price target on the stock.
Ratings data for HRTX provided by MarketBeat